Disease Information

Summary

X-linked adrenoleukodystrophy is a genetic disorder that mainly affects the nervous system and the adrenal glands, which are located on top of each kidney. In this disorder, the fatty covering (myelin) that insulates nerves in the brain and spinal cord tends to deteriorate (a condition called demyelination). The loss of myelin reduces the ability of the nerves to relay information to the brain. In addition, damage to the outer layer of the adrenal glands (adrenal cortex) causes a shortage of certain hormones (adrenocortical insufficiency). Adrenocortical insufficiency may cause weakness, weight loss, skin changes, vomiting, and coma. There are four distinct types of X-linked adrenoleukodystrophy: a childhood cerebral form, an adrenomyeloneuropathy type, an adrenal insufficiency only form, and a type called asymptomatic. The childhood cerebral form of X-linked adrenoleukodystrophy typically occurs in boys. Girls are rarely affected with this type. If not treated, affected boys experience learning and behavioral problems that usually begin between the ages of 4 and 10. Over time the symptoms can worsen, and children may have difficulty reading, writing, understanding speech, and comprehending written material. Additional signs and symptoms of the cerebral form include aggressive behavior, vision problems, difficulty swallowing, poor coordination, and impaired adrenal gland function. The rate at which this disorder progresses is variable but can be extremely rapid, often leading to total disability within a few years. The life expectancy of individuals with this type depends on whether early diagnosis and treatment are available. Without treatment, individuals with the cerebral form of X-linked adrenoleukodystrophy usually survive only a few years after symptoms begin. Signs and symptoms of the adrenomyeloneuropathy type appear between early adulthood and middle age. Affected individuals develop progressive stiffness and weakness in their legs (paraparesis), experience urinary and genital tract disorders, and often show changes in behavior and intellectual function. Most people with the adrenomyeloneuropathy type also have adrenocortical insufficiency. Some severely affected individuals develop cerebral X-linked adrenoleukodystrophy.  People with X-linked adrenoleukodystrophy whose only symptom is adrenocortical insufficiency are said to have the adrenal insufficiency only form. In these individuals, adrenocortical insufficiency can begin anytime between the first year of life and adulthood. However, most affected individuals develop the additional features of cerebral X-linked adrenoleukodystrophy in childhood or the adrenomyeloneuropathy type by the time they reach middle age. The life expectancy of individuals with the adrenal insufficiency form depends on the severity of the signs and symptoms, but typically this is the mildest of the three types. Children with the asymptomatic form do not appear to have any symptoms of X-linked adrenoleukodystrophy, but medical testing may show brain or biochemical abnormalities. Some individuals with the asymptomatic form may develop features of other types of X-linked adrenoleukodystrophy later in life. Rarely, individuals with X-linked adrenoleukodystrophy develop multiple features of the disorder in adolescence or early adulthood. In addition to adrenocortical insufficiency, these individuals usually have psychiatric disorders and a loss of intellectual function (dementia). It is unclear whether these individuals have a distinct form of the condition or a variation of one of the previously described types. For reasons that are unclear, different forms of X-linked adrenoleukodystrophy can be seen in affected individuals within the same family.

About Adrenoleukodystrophy

Many rare diseases have limited information. Currently, GARD aims to provide the following information for this disease:

  • Symptoms:May start to appear at a variety of ages.
  • Cause:This disease has more than one possible cause.
  • Organizations:Patient organizations dedicated to this rare disease are available on GARD, or you may contact a GARD Information Specialist for additional information.
  • Newborn Screening:This disease may be detected through newborn screening tests performed soon afterbirth.(Newborn screening tests may detect diseases before symptoms develop. If test results are abnormal, follow up with your medical team for additional testing and treatment options.)
  • Categories:Genetic diseases(Genetic diseases affect the DNA, or genetic instructions, which directs how tissues, organs, and body systems function.)Neurological diseases(Neurological diseases affect the brain, spinal cord, cranial nerves, autonomic nerves, or other peripheral nerves.)Endocrine diseases(Endocrine diseases affect hormone production or how the body responds to a specific hormone(s).)Inherited Metabolic diseases(Inherited metabolic diseases, or inborn errors of metabolism, are a group of genetic diseases that affect the ability of the body's cells to convert food into energy.) Leukodystrophies(Leukodystrophies are a group of genetic neurological diseases that affect the white matter of the brain and spinal cord.)

Resource(s) for Medical Professionals and Scientists on This Disease:

Resource(s) for Medical Professionals and Scientists on This Disease:

About Adrenoleukodystrophy

Many rare diseases have limited information. Currently, GARD aims to provide the following information for this disease:

  • Symptoms:May start to appear at a variety of ages.
  • Cause:This disease has more than one possible cause.
  • Organizations:Patient organizations dedicated to this rare disease are available on GARD, or you may contact a GARD Information Specialist for additional information.
  • Newborn Screening:This disease may be detected through newborn screening tests performed soon afterbirth.(Newborn screening tests may detect diseases before symptoms develop. If test results are abnormal, follow up with your medical team for additional testing and treatment options.)
  • Categories:Genetic diseases(Genetic diseases affect the DNA, or genetic instructions, which directs how tissues, organs, and body systems function.)Neurological diseases(Neurological diseases affect the brain, spinal cord, cranial nerves, autonomic nerves, or other peripheral nerves.)Endocrine diseases(Endocrine diseases affect hormone production or how the body responds to a specific hormone(s).)Inherited Metabolic diseases(Inherited metabolic diseases, or inborn errors of metabolism, are a group of genetic diseases that affect the ability of the body's cells to convert food into energy.) Leukodystrophies(Leukodystrophies are a group of genetic neurological diseases that affect the white matter of the brain and spinal cord.)

Causes

What Causes This Disease?

Genetic Mutations

Genetic Mutations

Known Genetic Mutations

What causes disruption in metabolism?

Damaged White Matter in CNS


Can diseases be passed down from parent to child?

X-Linked

X-Linked

When Do Symptoms of Adrenoleukodystrophy Begin?

Symptoms of this disease may start to appear at a variety of ages.

The age symptoms may begin to appear differs between diseases. Symptoms may begin in a single age range, or during several age ranges. The symptoms of some diseases may begin at any age. Knowing when symptoms may have appeared can help medical providers find the correct diagnosis.
  1. Prenatal
    Before Birth
  2. Newborn
    Birth-4 weeks
  3. Infant
    1-23 months
  4. Child Selected
    2-11 years
  5. Adolescent Selected
    12-18 years
  6. Adult Selected
    19-65 years
  7. Older Adult Selected
    65+ years
Symptoms may start to appear at a variety of ages.

Symptoms

You may have one or more symptoms, and they may be mild or severe. Having some or all of these symptoms does not mean you have this disease. Only a health care provider can diagnose you.

Common

Many people have these, but not everyone.

  • Abnormal gait (Gait disturbance)
  • Abnormality of adrenal physiology
  • Abnormality of vision
  • Adrenal insufficiency
  • Aggressive behavior
  • Attention deficit (Attention deficit hyperactivity disorder)
  • Behavioral abnormality (Atypical behavior)
  • Clumsiness
  • Cognitive impairment
  • Dementia
  • Difficulty finding words (Aphasia)
  • Disinhibition
  • Functional motor deficit
  • Headache
  • Inappropriate sexual behavior (Abnormal sexual behavior)
  • Incoordination
  • Increased circulating ACTH level
  • Intellectual disability
  • Laboratory abnormality (Abnormality of metabolism/homeostasis)
  • Lack of bladder control due to nervous system injury (Neurogenic bladder)
  • Leg muscle stiffness
  • More active than typical (Hyperactivity)
  • Partial loss of field of vision (Visual field defect)
  • Partial paralysis of legs (Paraparesis)
  • Progressive hearing impairment
  • Progressive spastic paraparesis
  • Rise in pressure inside skull (Increased intracranial pressure)
  • Somatic sensory dysfunction
  • Specific learning disability
  • Urinary bladder sphincter dysfunction
  • Visual impairment
  • Visual loss
  • Weakness of one side of body (Hemiparesis)

Uncommon

Some people have these, but most people do not.

  • Difficulty getting a full erection (Impotence)
  • Double vision (Diplopia)
  • Paralysis

Navigating Health Care Decisions

On average, it can take more than six years to receive an accurate diagnosis. Many primary care providers (PCPs) may not be familiar with rare diseases, and patients often need to visit multiple specialists or seek second opinions to get answers.

If a diagnosis remains unclear, visiting a multidisciplinary care center or university hospital may help. These centers bring together teams of specialists who can work together to evaluate symptoms and coordinate a diagnosis. This team-based approach is also helpful after a diagnosis, when managing care for rare diseases.

Because only about 5% of rare diseases have FDA-approved treatments, finding the right healthcare team to manage your symptoms and overall health is essential. People living with rare diseases often face challenges such as delayed diagnosis, limited treatment options, and difficulty accessing knowledgeable providers. Building a care team that understands your needs can make a significant difference in your quality of life.

Your Health Care Team

Why is building the right health care team important?

Building the right health care team is key to the diagnosis, treatment, and management of your long-term health journey living with a rare disease. Start by choosing a primary care provider (PCP). Your PCP will be your main point of contact and help coordinate care with other medical professionals. Your PCP may order tests or refer you to specialists. To find a PCP near you, use the Medicare provider search tool and enter your location and “Primary Care Provider.”

Seeing multiple specialists is important for people with rare diseases because these conditions often affect many parts of the body and require care from doctors with different expertise. Most primary care providers may not be familiar with rare diseases, so involving specialists can lead to a more accurate diagnosis and better care. A coordinated team approach ensures that all symptoms are addressed and that care is well-managed. It can also connect patients with the latest research or treatment options.

A PCP that specializes in the care of children is called a pediatrician. Use this tool by the American Academy of Pediatrics to find a pediatrician in your area by inputting your location.

These specialists may help in the diagnosis, management, and treatment of Adrenoleukodystrophy:

Multidisciplinary Care Centers

Is It Time to Get a Second Opinion or Specialized Evaluation?

If you've visited your PCP, met with specialists, and undergone the recommended tests, but are still searching for a diagnosis, it may be time to visit an academic medical center or, for pediatric patients, a children's hospital. Academic medical centers and children's hospitals, often called multidisciplinary care centers, typically bring together specialists from different fields to work together on complex cases like rare diseases.

Multidisciplinary care centers may offer more coordinated care and be involved in clinical research, which may help reduce the time to diagnosis and provide access to emerging diagnostic tools. Specialists at these centers may have a deeper understanding of rare diseases and serve as a resource when you'd like a second opinion, particularly when test results or treatment plans are not delivering expected results.

Find hospitals that may partner with medical schools and programs in your area. 

Children’s hospitals and large teaching hospitals may also offer dedicated specialists and programs for pediatric patients with undiagnosed or rare diseases. These programs bring pediatric experts together in one place and may provide more coordinated care for your child.

Search for children's or university hospitals in your area.


Rare Disease Experts

How can you find a rare disease expert?

If a diagnosis, care management, or treatment plan remains unclear despite extensive efforts by your PCP and specialists, it may be time to find a rare disease expert for your disease, if available. A rare disease expert is a medical provider that has knowledge or training on specific rare disease(s), but there may only be a few experts in your state, region, or country. Rare disease experts may work at large research or teaching hospitals, sometimes called centers of excellence. Centers of Excellence commit to sharing knowledge and best practices that can lead to improved care and treatment for individuals living with a rare disease. 

You can also contact a GARD Information Specialist for help finding experts, centers of excellence, or clinics that focus on your disease.

Find Your Community

How can patient organizations help?

Patient organizations can help patients and families connect. They build public awareness of the disease and are a driving force behind research to improve patients' lives. They may offer online and in-person resources to help people live well with their disease. Many collaborate with medical experts and researchers.

Services of patient organizations differ, but may include:

  • Ways to connect to others and share personal stories
  • Easy-to-read information
  • Up-to-date treatment and research information
  • Patient registries
  • Lists of specialists or specialty centers
  • Financial aid and travel resources


Please note: GARD provides organizations for informational purposes only and not as an endorsement of their services. Contact a GARD Information Specialist for more information on organizations that may be dedicated to this disease. Please contact an organization directly if you have questions about the information or resources it provides.


View GARD's criteria for including patient organizations, which can be found under the FAQs on our About GARD page. Request an update or to have your organization added to GARD. 

Patient Organizations

15 Organizations

People With

Adrenoleukodystrophy

Country

United States

People With

Adrenoleukodystrophy

Country

United States

People With

Adrenoleukodystrophy

Country

United States

People With

Adrenoleukodystrophy

Helpful Links
Country

United States

People With

Adrenoleukodystrophy

Country

People With

Adrenoleukodystrophy

Country

United States

People With

Adrenoleukodystrophy

Country

People With

Adrenoleukodystrophy

Country

United States

People With

Adrenoleukodystrophy

Country

People With

Adrenoleukodystrophy

Country

People With

Adrenoleukodystrophy

Country

People With

Adrenoleukodystrophy

Country

United States

People With

Epilepsy

Country

United States

People With

Infertility

Helpful Links
Country

United States

People With

Leukodystrophies

Helpful Links
Country

United States

OrganizationPeople WithHelpful LinksCountry
ALD AllianceAdrenoleukodystrophyList of Experts
Research Registry
United States
Global DARE FoundationAdrenoleukodystrophyList of Experts
Research Registry
United States
National Adrenal Diseases FoundationAdrenoleukodystrophyList of Experts
Research Registry
United States
ALD ConnectAdrenoleukodystrophyList of ExpertsUnited States
Arrivederci ALDAdrenoleukodystrophy
Ben's FriendsAdrenoleukodystrophyUnited States
Fight ALDAdrenoleukodystrophy
Hunter's Hope FoundationAdrenoleukodystrophyUnited States
Leukodystrophy Resource & Research OrganisationAdrenoleukodystrophy
RARE-XAdrenoleukodystrophy
Remember The GirlsAdrenoleukodystrophy
The Stop ALD FoundationAdrenoleukodystrophyUnited States
Epilepsy FoundationEpilepsyList of Experts
Research Registry
United States
Resolve: The National Infertility AssociationInfertilityList of ExpertsUnited States
United Leukodystrophy FoundationLeukodystrophiesList of ExpertsUnited States

Participate in Research

Clinical studies are a part of clinical research and play an important role in medical advances for rare diseases. Through clinical studies, researchers may ultimately uncover better ways to treat, prevent, diagnose, and understand human diseases.

What Are Clinical Studies?

Clinical studies are medical research involving people as participants. There are two main types of clinical studies:

  1. Clinical trials determine if a new test or treatment for a disease is effective and safe by comparing groups receiving different tests/treatments.
  2. Observational studies involve recording changes over time among a specific group of people in their natural settings.

Learn more about clinical trials from this National Institutes of Health webpage.

Why Participate in Clinical Studies?

People participate in clinical trials for many reasons. People with a disease may participate to receive the newest possible treatment and additional care from clinical study staff as well as to help others living with the same or a similar disease. Healthy volunteers may participate to help others and to contribute to moving science forward.

To find the right clinical study we recommend you consult your doctors, other trusted medical professionals, and patient organizations. Additionally, you can use ClinicalTrials.gov to search for clinical studies by disease, terms, or location.

What if There Are No Available Clinical Studies?

Why may you want to consider joining the All of Us Research Program?

ClinicalTrials.gov, an affiliate of NIH, provides current information on clinical research studies in the United States and abroad. Talk to a trusted doctor before choosing to participate in any clinical study. We recommend checking this site often and searching for studies with related terms/synonyms to improve results.
Search ClinicalTrials.gov for this disease.

GARDGenetic and Rare Diseases
Information Center
Contact a GARD Information Specialist if you need help finding more information on this rare disease or available clinical studies. Please note that GARD cannot enroll individuals in clinical studies.
Contact GARD
Please allow 2 to 10 business days for us to respond.

Sources & References

Last Updated: September 2026